• Sencilia raised about €2 million in a financing round led by NOM, with participation from Future Tech Ventures alongside other investors.
• The Groningen-based medical technology startup develops Rely-V sensors to monitor intravenous medication flow, initially targeting babies and children.
• Proceeds will support production readiness, clinical data collection and partnerships with infusion pump and tubing manufacturers.
• The financing follows an initial investment in August 2025.
• Sencilia also receives a grant through the European Eureka Eurostars program and an innovation loan from Rabobank.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Future Tech Ventures published the original content used to generate this news brief on October 29, 2026, and is solely responsible for the information contained therein.